M&A Deal Summary

Kova International Acquires Biochemical Diagnostics

On April 22, 2016, Kova International acquired life science company Biochemical Diagnostics

Acquisition Highlights
  • This is Kova International’s 1st transaction in the Life Science sector.
  • This is Kova International’s 1st transaction in the United States.
  • This is Kova International’s 1st transaction in New York.

M&A Deal Summary

Date 2016-04-22
Target Biochemical Diagnostics
Sector Life Science
Buyer(s) Kova International
Deal Type Add-on Acquisition

Target

Biochemical Diagnostics

Edgewood, New York, United States
Biochemical Diagnostics, Inc. is a manufacturer and marketer of controls and disposable sample preparation products used in drugs of abuse testing. Biochemical Diagnostics products are utilized in toxicology and clinical laboratories and also in handheld devices for point of care testing, Biochemical Diagnostics was founded in 1981 and is based in Edgewood, New York.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Kova International

Garden Grove, California, United States

Category Company
Founded 1981
Sector Life Science
DESCRIPTION

Kova International is a developer, manufacturer, and marketer of in-vitro diagnostic products for the global urinalysis market. Kova International was founded in 1981 and is based in Garden Grove, California.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: New York M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2016 M&A 1 of 1